Dr. Philip McMillan, John McMillan
In early 2024, a medical professional with over 20 years of experience working in a catheterization lab in the United States contacted the Vejon Health YouTube channel with alarming information. He provided testimony and documentary evidence that the unusual blood clots that embalmers had been reporting since 2021 were not just a post-mortem phenomenon. They were also occurring in living patients, and at an alarming rate. However, it is important to note that this evidence has not been independently verified or corroborated by other sources.
The decision to break his silence was driven by a sense of moral desperation after observing an increasing frequency of abnormal, fibrous blood clots in patients undergoing various procedures starting in late 2021. At considerable risk to his career, he shared his observations, including detailed descriptions and images, suggesting that a significant and potentially dangerous change was occurring in blood clot formation among the living.
Other medical professionals and researchers around the world have been quietly observing an increase in the incidence of unusual blood clots in COVID-19 patients and individuals following vaccination. However, the controversial nature of these observations, coupled with the stigma associated with criticizing COVID-19 vaccines and potential reputational damage, has led many to remain silent. This reluctance to speak out has unfortunately resulted in a lack of scientific investigation into the underlying mechanisms of these clots and their possible connections to the SARS-CoV-2 virus and vaccination campaigns.
The COVID-19 Connection
The relationship between COVID-19 and blood clots has been well-established since the early stages of the pandemic. A study published in the National Center for Biotechnology Information (NCBI) reported that venous thromboembolism (VTE) occurs in 22.7% of COVID-19 patients in intensive care units and 8% in non-ICU hospitalized patients. This high incidence of clotting events in COVID-19 patients suggests that the virus itself plays a significant role in altering the body’s coagulation processes.
One proposed mechanism involves the virus’s impact on the endothelial cells lining blood vessels. SARS-CoV-2 can directly infect these cells, leading to inflammation and damage. This endothelial injury can trigger a coagulation cascade, resulting in the formation of blood clots. Additionally, the intense inflammatory response associated with severe COVID-19 can further contribute to a hypercoagulable state.
Vaccine-Induced Thrombosis: A Rare but Significant Concern
While vaccines been used in combating the COVID-19 pandemic, reports of blood clotting events following vaccination have emerged. The European Medicines Agency (EMA) identified a possible link between the AstraZeneca COVID-19 vaccine and cases of unusual blood clots combined with low blood platelets. These events, termed vaccine-induced immune thrombotic thrombocytopenia (VITT), have been observed primarily in individuals under 60 years of age within two weeks of vaccination.
The mechanism behind VITT is thought to involve an aberrant immune response. In some rare cases, the vaccine may trigger the production of antibodies that activate platelets, leading to both clot formation and a decrease in platelet count. This phenomenon is similar to heparin-induced thrombocytopenia, a rare reaction to the anticoagulant heparin.
The Embalmer’s Clot Phenomenon
A particularly intriguing aspect of the post-2021 blood clot enigma is the observation of unusually large, fibrous clots by embalmers. These “mega clots,” as they’ve been termed, have been reported in both deceased individuals and, more alarmingly, in living patients undergoing catheterization procedures.
The characteristics of these clots differ significantly from typical blood clots. They are described as having a tough, fibrous texture throughout, sometimes reaching lengths of up to two feet. Their resistance to standard treatments like heparin and tissue plasminogen activator (TPA) further sets them apart from conventional clots.
One proposed mechanism for the formation of these unusual clots involves the vasa vasorum, the network of small blood vessels that supply oxygen to the walls of larger blood vessels. A study published in May 2024 discussed thrombosis of the vasa vasorum in large and medium-sized pulmonary arteries, which may provide insights into the formation of these mega clots.
Inflammation and damage to the vasa vasorum could lead to exposure of underlying tissues, triggering the clotting process. The resulting clots may then grow and extend along the length of blood vessels, forming the large, fibrous structures observed by embalmers and medical professionals.
Potential Treatments and Preventive Measures
Given the unique nature of these clots, standard anticoagulation therapies may prove less effective. For VITT, early recognition and treatment are crucial. Current approaches include the use of non-heparin anticoagulants, high-dose intravenous immunoglobulin, and in some cases, plasma exchange to remove the offending antibodies.
For the larger, fibrous clots, mechanical thrombectomy using specialized devices may be necessary. However, the development of new treatments that can effectively break down these resistant clots will require active research.
Preventive measures might focus on identifying high-risk individuals and optimizing their care. This could include careful monitoring of patients with COVID-19, especially those with severe disease, and implementing appropriate thromboprophylaxis strategies.
The increase in unusual blood clots since 2021 presents a complex challenge to the medical and scientific communities. Many questions remain unanswered, and further research is needed to fully understand the causes of these clots, develop effective treatments, and implement strategies to prevent their formation. It is crucial that healthcare providers be allowed to freely report unusual clotting events without fear of stigmatization. Only by embracing scientific inquiry can we hope to address this emerging health concern and improve outcomes for affected individuals.
“While vaccines have been crucial in combating the COVID-19 pandemic,…”
Really? Not my understanding. Do you have any supporting evidence?
Would suggest alternatively:
Vaccines have been crucial in:
1) initiating and perpetuating the ongoing immune escape pandemic
2) causing significant excess mortality in all age groups
3) enriching medical professionals and pharma industry in the west
4) revealing that many people in public health and medicine are frauds and grifters (and most are cowards)
I’m somewhat nervous about taking a prescribed corticosteroid medication considered I could have micro-clots in my brain!